Track topics on Twitter Track topics that are important to you
The neuromodulation technology utilizes devices that bring about a change in nervous system either by stimulation or modulating brain activity. The treatment delivered by neuromodulation devices brings about life changing transformation in patients who fail to get better by traditional approaches. The opportunities to development new therapies for a wide variety of neurological and psychological conditions are attracting lot of companies, start ups and investments. According to IQ4I analysis, the global neuromodulation devices market is expected to grow at a double digit CAGR to reach $9.3 billion by 2021. Factors driving the neuromodulation market include, projected increase in patients with chronic pain, neurodegenerative diseases, psychiatric conditions, improvements in technology such as miniaturization, better battery technology, use of bioactive coatings are all contributing for growth of neuromodulation devices market whereas risk of side effects, availability of alternative treatment and high initial cost of implants are the factors hampering the market growth. Advancement of technology with its wide application areas shows that neuromodulation devices market has vast opportunities in the coming years.
Neuromodulation devices market is segmented on the basis of technology as internal and external neuromodulation. The internal neuromodulation is again classified into Spinal Cord Stimulation SCS, Deep Brain Stimulation DBS, Vagus Nerve Stimulation VNS, Sacral Nerve Stimulation SNS and Other with Gastric Electric Stimulation GES and Respiratory Electrical Stimulation RES/Phrenic Nerve Stimulation PNS. Based on the application the neuromodulation devices market is segmented into Chronic Pain, Movement Disorders, Psychiatric Conditions, Gastroenterology Urology and other applications. Based on endusers the market is segmented into hospitals and private neuromodulation clinics.
North America accounts for the highest market share of 56.1% followed by Europe. Steep rise in ageing population, advancement in technology, awareness of people and favourable government policies makes U.S. the leader of neuromodulation devices market. However, Asian countries especially India and China are the fast growing regions with its growing demand for neuromodulation devices.
Major players in Neuromodulation devices market include Medtronic Ireland, Boston Scientific U.S., Cyberonics U.S., St. Jude Medical U.S., Neurometrix, Inc U.S., Neuronetics, Inc U.S., Nevro Corporation U.S., Synapse Biomedical U.S., Avery Biomedical U.S. and Magstim U.K..
The report provides an in depth market analysis of the above mentioned segments across the following regions:
Rest of the World RoW
Pain is a feeling (sharp or dull) triggered in the nervous system which can be transient or constant. Pain can be specific to one area of the body eg back, abdomen or chest or more general all over the body eg muscles ache from the flu. Without pain ...
Psychiatry is the study of mental disorders and their diagnosis, management and prevention. Conditions include schizophrenia, severe depression and panic disorders among others. There are pharmaceutical treatments as well as other therapies to help...